Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms

PCA plots showing discrimination between patients with mitotane ingestion (blue) and without mitotane ingestion (red) in reverse phase (RP) in both (A) ESI and (B) ESI- mode. Supervised OPLS-DA plots showing differences between the two groups in both (C) ESI and (D) ESI- mode. S-plot correlative analysis showing significant variables not correlated with patients with mitotane ingestion (highlighted in red) in both (E) ESI and (F) ESI- mode.